performed 2x2 table analysis of relationships between the scores for each papillary feature at the level of the papillum and the level of the kidney. Finally, we calculated mean scores for each feature by kidney and used Pearson correlation coefficients to measure relationships between features at the kidney level.
performed 2x2 table analysis of relationships between the scores for each papillary feature at the level of the papillum and the level of the kidney. Finally, we calculated mean scores for each feature by kidney and used Pearson correlation coefficients to measure relationships between features at the kidney level.
RESULTS: 85 patients were included with a total of 361 papillae graded. In Figure 2 . At the level of the kidney, the strongest relationship exists between mean RP and mean contour scores (r p ¼0.4630, p¼0.0003).
CONCLUSIONS: These data support our critical hypothesis that RP and attached calcium stone complex are shed from the papillum leaving behind a pitting defect on the papillary surface, which can then either heal over or, with repeated insult, progress to loss of papillary contour. We believe that understanding this sequence helps link renal physiology to a urologic endpoint. METHODS: Wild-type (n¼6) and Agxt KO (n¼6) mice were placed on an ultra-low oxalate diet. The mice were subcutaneously administered 4 weekly doses (10mg/kg) of LDHA siRNA (Alnylam Pharmaceuticals). 24-hour urine samples were collected at baseline and following 4 weeks of LDHA siRNA treatment. Plasma, liver and muscle tissue were collected at completion of the study. Urinary, plasma, and tissue metabolites were measured using ion chromatography/mass spectrometry (oxalate, glycolate and lactate) and high pressure liquid chromatography (pyruvate and glyoxylate). LDH specific activity was determined in tissue lysates with either lactate or glyoxylate as the assay substrate and measuring the rate of reduction of NAD at 340nm at pH 9.0. Statistical analysis was performed utilizing Student t-test.
RESULTS: There was a >98% decrease in liver specific LDH activity utilizing glyoxylate as a substrate, and >56% decrease in liver specific LDH activity with lactate as a substrate. There was no change in LDH activity in muscle and heart tissue lysates following LDHA siRNA treatment. Changes in urine, plasma and liver metabolites with LDHA siRNA treatment are shown in Table 1 .
CONCLUSIONS: Knock down of hepatic LDHA using siRNA results in a profound decrease in urinary oxalate excretion in both Wt and Agxt KO mice suggesting this approach may be an effective therapy for primary hyperoxaluria syndromes as well as idiopathic hyperoxaluria. Liver, plasma, and urinary glycolate levels were reduced after treatment suggesting liver LDH activity plays an important role in whole body glycolate metabolism. The long-term consequences of a decrease in the liver lactate pyruvate ratio with LDHA siRNA warrants further investigation. Source of Funding: Rare Kidney Stone Consortium Vol. 199, No. 4S, Supplement, Friday, May 18, 2018 THE JOURNAL OF UROLOGY â e73
